Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Stefan Almestrand"'
Autor:
Stefan Almestrand, Xiao Wang, Åsa Jeppsson-Ahlberg, Marcus Nordgren, Jenny Flygare, Birger Christensson, Stephan Rössner, Birgitta Sander
Publikováno v:
PeerJ, Vol 3, p e1056 (2015)
The cannabinoid receptor type 1 (CB1) antagonist rimonabant has been used as treatment for obesity. In addition, anti-proliferative effects on mitogen-activated leukocytes have been demonstrated in vitro. We have previously shown that rimonabant (SR1
Externí odkaz:
https://doaj.org/article/60395bae457d4a6f9e4363c145c15362
Autor:
Eva Kimby, Björn E. Wahlin, Agata M. Wasik, Patrik Andersson, Fang Zong, Lina Nygren, Stefan Almestrand, Jenny Flygare, Stefanie Baumgartner Wennerholm, Birger Christensson, Birgitta Sander, Leonie Saft
Publikováno v:
Oncoscience
The cannabinoid receptors are upregulated in many types of cancers, including mantle cell lymphoma (MCL) and have been suggested to constitute novel therapeutic targets. The expression pattern of the key members of the endocannabinoid system was anal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62b4d1ef44c52bf4f9a696122ff4fe89
https://doi.org/10.18632/oncoscience.77
https://doi.org/10.18632/oncoscience.77
Autor:
Marcus Nordgren, Xiao Wang, Åsa Jeppsson-Ahlberg, Stefan Almestrand, Birger Christensson, Stephan Rössner, Birgitta Sander, Jenny Flygare
Publikováno v:
PeerJ, Vol 3, p e1056 (2015)
PeerJ
PeerJ
The cannabinoid receptor type 1 (CB1) antagonist rimonabant has been used as treatment for obesity. In addition, anti-proliferative effects on mitogen-activated leukocytes have been demonstrated in vitro. We have previously shown that rimonabant (SR1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf1e43f06756cec57559008d6d5176ac
https://peerj.com/articles/1056.pdf
https://peerj.com/articles/1056.pdf
Autor:
Birgitta Sander, Eva Kimby, Dackland Ål, Agata M. Wasik, Patrik Andersson, Xiao Wang, Birger Christensson, Hultenby K, Stefan Almestrand
Publikováno v:
Cell Death & Disease
Cannabinoid receptors 1 (CB1) and/or 2 (CB2) are overexpressed in many types of human malignancies including mantle cell lymphoma (MCL). Agonists to CB1 and CB2 promote ceramide de novo synthesis, p38–mitogen-activated protein kinase-dependent acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f63962ce866b0a545690d3abf76aa0
https://pubmed.ncbi.nlm.nih.gov/22048168
https://pubmed.ncbi.nlm.nih.gov/22048168